1. Introduction {#s0005}
===============

Spinal muscular atrophy (SMA) is a severe neuromuscular disease characterized by degeneration of the alpha motor neurons of the spinal cord associated with progressive symmetric weakness and atrophy of the limb muscles ([@bb0025]). Different phenotypes identified in this disease were usually classified into three groups according to the age of onset and severity of the clinical symptoms, i) acute Werdnig--Hoffmann (type I), ii) intermediate Werdnig--Hoffmann (type II), and iii) Kugelberg--Welander disease (type III) ([@bb0015]). Molecular investigations had indicated that all these three types of disease were linked to the SMA critical region on chromosome 5q13 ([@bb0005], [@bb0060], [@bb0065]). A large duplication in this region contains two centromeric and telomeric homologous copies of at least 4 genes including survival motor neuron (*SMN*), neuronal apoptosis inhibitory protein (*NAIP*), *p44* gene, a subunit of transcription factor *TFIIH* and *H4F5* ([@bb0045], [@bb0095], [@bb0010], [@bb0100]). Deletions of telomeric copy of *SMN* (*SMNt*) have been observed in approximately 95% of the SMA patients ([@bb0135]). However, deletions of other genes of SMA critical region have been found mainly in the severe forms of the disease ([@bb0110], [@bb0055], [@bb0100], [@bb0105], [@bb0030]). Moreover, several subtle mutations which cause rare cases of the SMA disease have been reported in different populations ([@bb0040], [@bb0130], [@bb0115]).

The SMA disease seems to be among the most common genetic diseases worldwide with an estimation of 1 in 6000 to 1 in 10,000 live births and the carrier frequency from 1:40 to 1:60 ([@bb0075], [@bb0080]). The frequency of the disease has been reported to be relatively high in the Iranian population. A recent report indicated a very high incidence of the disease with carrier frequency of 1 in 20 in the Iranian population ([@bb0035]). This indicated the high demand and the necessity of carrier detection and prenatal diagnosis of the SMA disease in the Iranian population.

The SMA gene region contains several polymorphic genetic markers including restriction fragment length polymorphisms (RFLPs) and short tandem repeats (STRs) ([@bb0120], [@bb0125], [@bb0020]). Polymorphic markers usually show various frequency and heterozygosity in different populations. Among the STRs present in the SMA gene region, D5S351 and D5S1414, which flank the critical region, could be used in molecular diagnosis of the SMA disease. However, no investigation has been performed on heterozygosity and allele frequency of these markers in the Iranian population. In the present study, we evaluated the polymorphism level and haplotype frequency of these two polymorphic markers in the Iranian population.

2. Material and methods {#s0010}
=======================

2.1. DNA samples {#s0015}
----------------

Blood samples were collected from 75 healthy unrelated healthy individuals and 25 Trios families (150 individuals). The Trios families included unrelated parents and at least one child. All the individuals were from the Iranian population. Genomic DNA was extracted from peripheral blood lymphocytes by standard salting out procedure ([@bb0070]).

2.2. Genotyping {#s0020}
---------------

D5S351 (UniSTS: 8886) and D5S1414 (UniSTS: 149791) markers located on the SMA critical region were genotyped. The genomic position of these two markers is represented in [Fig. 1](#f0005){ref-type="fig"}. Amplification condition for D5S1414 marker was as follows: 5 cycles consisting of primary denaturation at 94 °C for 9 min, denaturation at 94 °C for 15 s, annealing at 60 °C for 15 s, and extension at 72 °C for 30 s followed by 20 cycles consisting of denaturation at 94 °C for 15 s, annealing at 55 °C for 15 s, and extension at 72 °C for 30 s, followed by an extension period of 5 min at 72 °C. Temperature cycling conditions for D5S351 marker were as follows: primary denaturation 5 min, 94 °C; denaturation 15 s, 94 °C; annealing 15 s, 59 °C; extension 30 s, 70 °C; 23 cycles; final extension 5 min, 72 °C. Each 50 μL reaction contained 50 ng DNA, 5 μL of 500 mM KCl, 100 mM Tris--HCl (pH 8.4), 1--2 μl of 50 mM MgCl2, and 2 μL of 10 mM dNTP, 5 U SMQ-*Taq* DNA polymerase and 0.4 μL of 10 pM each primer.

The amplified alleles were resolved by vertical gel electrophoresis through 10% non-denaturing polyacrylamide gel. The alleles were isolated and sequenced on an ABI 737 sequencer (Perkin Elmer/ABI, Life Technologies, Germany).

2.3. Statistical analysis {#s0025}
-------------------------

Allele frequency, observed and expected heterozygosity were calculated with GENEPOPE sofware ([@bb0090]). The matching probability (pM), power of discrimination (*PD*) and exclusion (*PE*), polymorphism information content (*PIC*) and typical paternity index (*PItypical*) were calculated by use of the PowerStats Microsoft Excel workbook template provided by promega cooperation (<http://www.promega.com/geneticidtools/powerstats/>).

The genotype data obtained from 25 trios families and 75 unrelated individuals were used to estimate the haplotype frequency by use of FBAT and PHASE programs, respectively ([@bb0085], [@bb0050]). We also used 2LD program for the estimation of linkage disquilibrium (LD) between D5S351 and D5S1414 markers in the studied population ([@bb0140]).

3. Results {#s0030}
==========

In the present study, two STR markers including D5S351 and D5S1414 located in the SMA critical region were genotyped. The allele frequency distributions and heterozygosity of the markers were determined. Moreover, several statistical values including matching probability (pM), power of discrimination (*PD*) and exclusion (*PE*), polymorphism information content (*PIC*) and typical paternity index (*PItypical*) were determined. As presented in [Table 1](#t0005){ref-type="table"}, a total of 15 different alleles for the markers were observed including six for D5S351 and nine for D5S1414 marker. The allele frequencies ranged from 0.007 to 0.393. The observed heterozygosity of D5S351 and D5S1414 were 51 and 52%, respectively. The highest PIC and PD was observed in D5S1414 marker (PIC: 0.82; PD: 0.940).

The haplotype frequency of haplotype D5S351--D5S1414 estimated by FBAT and PHASE programs is shown in [Table 2](#t0010){ref-type="table"}. The haplotypes 19--17, 19--16, 17--14, 17--17, 17--18 and 19--20 were shown the frequency \> 0.05, indicating these haplotypes could be introduced as informative haplotypes of D5S351--D5S1414 in the Iranian population.

The D′ coefficient for haplotype D5S351--D5S1414 was estimated 0.396. The χ^2^ value for this haplotype obtained by means 2LD program was 82.43 (df = 40), revealing that the estimated χ^2^ value was higher than χ^2^ value obtained by using χ^2^ table (p \< 0.05). The obtained results were supported from partially linkage between these two markers in the Iranian population.

4. Discussion {#s0035}
=============

The purpose of the present study was to investigate the allele frequency and haplotype estimation of two short tandem repeat (STR) markers, D5S351 and D5S1414 in the Iranian population. The data indicated that two studied STRs could suggest as informative markers in linkage analysis and molecular diagnosis of SMA mutations in the Iranian population.

The data showed the presence of six different alleles for the D5S351 marker in the studied population. The identified alleles were corresponded to 17, 18, 19, 20, 21 and 22 repeats of CA sequence ([Table 1](#t0005){ref-type="table"}). Also, nine alleles were identified for D5S1414 marker including 12, 13, 14, 15, 16, 17, 18, 19, 20 repeats of the CA sequence. The most common allele for D5S351 and D5S1414 marker were 19 and 17, and the alleles with 20 and 12 CA repeats had the lowest frequency, respectively ([Table 1](#t0005){ref-type="table"}). The heterozygosity of the D5S351 and D5S1414 markers were almost 50%, indicating these two markers were suitable in linkage analysis status in SMA families ([Table 1](#t0005){ref-type="table"}). The discrimination power of these markers was very high. Therefore, these markers could also be used to distinguish between two unrelated people, suggesting that these markers could be applicable in forensic testing and individual identification in the Iranian population. Although, the markers have not been reported to be used in forensic testing in other populations yet, however, in view of the present data, they could be suggested to be examined as possible informative markers for other populations. Obviously, their power of discrimination needs to be tested in other populations before their application as useful markers in forensic testing.

Among 54 estimated possible haplotypes for D5S351--D5S1414, thirty three haplotypes was found in the studied population. Six haplotypes, including 19--17, 19--16, 17--14, 17--17, 17--18 and 19--20, showed the frequency \> 0.05 in the studied population. These haplotypes were introduced as informative haplotypes for D5S351--D5S1414 in the Iranian population. In contrast, haplotypes such as 22--17, 21--19, 17--16 and 21--18 which showed different frequency using FBAT and PHASE with at least in one program \< 0.05, could not be considered as informative. The estimation of D′ coefficient and χ^2^ value of D5S351--D5S1414 revealed the presence of linkage disequilibrium between the two STR markers. However, these markers were not in complete linkage disequilibrium. The obtained data from D5S351--D5S1414 haplotypes study could be utilized as advantageous tools in analysis of all transmission in molecular diagnosis SMA disease.

In this study, the investigation of D5S351 and D5S1414 polymorphic markers revealed that these two markers could be used as informative markers in molecular diagnosis of SMA disease in families with an affected child. Moreover, our results indicated that these markers are suitable in personal identification for legal purposes among the Iranian population.
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![Diagrammatic representation of the location of D5S351 and D5S1414 markers at the SMA critical region. CEN, centromer; TEL, telomere; NIAP, Neural inhibitory apoptosis protein.](gr1){#f0005}

###### 

Allele frequency and statistical values estimated for D5S351 and D5S1414 markers in the Iranian population.

  Allele (the number of repeats)   D5S351   D5S1414
  -------------------------------- -------- ---------
  12                                        0.007
  13                                        0.040
  14                                        0.153
  15                                        0.087
  16                                        0.127
  17                               0.307    0.280
  18                               0.053    0.073
  19                               0.393    0.113
  20                               0.027    0.120
  21                               0.120    
  22                               0.100    
  *H*obs                           51%      52%
  *H*exp                           55%      63%
                                            
  *Forensic statistics*                     
  pM                               0.132    0.060
  PIC                              0.68     0.82
  PD                               0.868    0.940
                                            
  *Paternity statistics*                    
  PE                               0.398    0.418
  PIT                              1.56     1.63

*H*obs, observed heterozygosity; *H*exp, expected heterozygosity; pM, matching probability; PIC, polymorphism information content; PD, power of discrimination; PE, power of exclusion; PIT, typical paternity index.

###### 

The frequency of D5S351--D5S1414 haplotypes estimated by means of FBAT and PHASE programs in the Iranian population.

  D5S351--D5S1414 haplotype   FBAT frequency   PHASE frequency
  --------------------------- ---------------- -----------------
  19--17                      0.130000         0.141453
  19--16                      0.085000         0.087432
  17--14                      0.080000         0.081057
  17--17                      0.070000         0.062256
  17--18                      0.070000         0.057010
  19--20                      0.050000         0.065244
  21--14                      0.045000         0.037837
  19--14                      0.045000         0.031105
  17--20                      0.040000         0.034700
  19--19                      0.035000         0.035859
  21--17                      0.030000         0.029241
  19--15                      0.030000         0.024416
  22--17                      0.030000         0.054047
  21--19                      0.030000         0.015131
  17--13                      0.030000         0.022134
  21--15                      0.025000         0.022569
  17--16                      0.025000         0.011085
  18--17                      0.020000         0.029670
  17--19                      0.015000         0.024010
  21--20                      0.010000         0.016722
  18--19                      0.010000         0.013381
  22--19                      0.010000         0.011619
  17--12                      0.010000         0.008333
  19--18                      0.010000         0.015974
  18--16                      0.010000         0.008333
  20--16                      0.010000         0.008333
  21--16                      0.010000         0.018150
  17--15                      0.010000         0.016081
  18--13                      0.005000         0.004348
  18--15                      0.005000         0.002600
  19--13                      0.005000         0.006851
  21--18                      0.010000         0.002016
  22--15                      0.000000         0.001001
